OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A key role for the N/OFQ-NOP receptor system in modulating nicotine taking in a model of nicotine and alcohol co-administration
Andrea Cippitelli, Jennifer J. Schoch, Ginamarie Debevec, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Cebranopadol Blocks the Escalation of Cocaine Intake and Conditioned Reinstatement of Cocaine Seeking in Rats
Giordano de Guglielmo, Alessandra Matzeu, Jenni Kononoff, et al.
Journal of Pharmacology and Experimental Therapeutics (2017) Vol. 362, Iss. 3, pp. 378-384
Open Access | Times Cited: 40

NOP-Related Mechanisms in Substance Use Disorders
Roberto Ciccocioppo, Anna Maria Borruto, Ana Domi, et al.
Handbook of experimental pharmacology (2019), pp. 187-212
Open Access | Times Cited: 37

Neuropeptide systems and new treatments for nicotine addiction
Adriaan W. Bruijnzeel
Psychopharmacology (2016) Vol. 234, Iss. 9-10, pp. 1419-1437
Open Access | Times Cited: 36

NOP receptor antagonism reduces alcohol drinking in male and female rats through mechanisms involving the central amygdala and ventral tegmental area
Anna Maria Borruto, Yannick Fotio, Serena Stopponi, et al.
British Journal of Pharmacology (2019) Vol. 177, Iss. 7, pp. 1525-1537
Open Access | Times Cited: 29

Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors
Qianwei Shen, Yulin Deng, Roberto Ciccocioppo, et al.
Frontiers in Psychiatry (2017) Vol. 8
Open Access | Times Cited: 27

Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption
Marsida Kallupi, Qianwei Shen, Giordano de Guglielmo, et al.
Addiction Biology (2017) Vol. 23, Iss. 2, pp. 585-595
Open Access | Times Cited: 25

Nicotine and opioid co-dependence: Findings from bench research to clinical trials
Lilian Custodio, Samantha G. Malone, Michael T. Bardo, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 134, pp. 104507-104507
Closed Access | Times Cited: 19

NOP Receptor Antagonists Decrease Alcohol Drinking in the Dark in C57BL/6J Mice
Gloria Brunori, Michelle Weger, Jennifer J. Schoch, et al.
Alcoholism Clinical and Experimental Research (2019) Vol. 43, Iss. 10, pp. 2167-2178
Open Access | Times Cited: 20

Crosstalk between Opioid and Anti-Opioid Systems: An Overview and Its Possible Therapeutic Significance
Ewa Gibuła‐Tarłowska, Jolanta H. Kotlińska
Biomolecules (2020) Vol. 10, Iss. 10, pp. 1376-1376
Open Access | Times Cited: 19

Pharmacological blockage of NOP receptors decreases ventral tegmental area dopamine neuronal activity through GABAB receptor-mediated mechanism
Michele Petrella, Anna Maria Borruto, Lorenzo Curti, et al.
Neuropharmacology (2024) Vol. 248, pp. 109866-109866
Open Access | Times Cited: 2

Anti‐Parkinsonian and anti‐dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists
Ludovico Arcuri, Salvatore Novello, Martina Frassineti, et al.
British Journal of Pharmacology (2017) Vol. 175, Iss. 5, pp. 782-796
Open Access | Times Cited: 20

NOP receptor antagonism attenuates reinstatement of alcohol-seeking through modulation of the mesolimbic circuitry in male and female alcohol-preferring rats
Anna Maria Borruto, Yannick Fotio, Serena Stopponi, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 12, pp. 2121-2131
Open Access | Times Cited: 14

In Vitro and In Vivo Profile of PPL-101 and PPL-103: Mixed Opioid Partial Agonist Analgesics with Low Abuse Potential
Taline V. Khroyan, Andrea Cippitelli, Nicholas Toll, et al.
Frontiers in Psychiatry (2017) Vol. 8
Open Access | Times Cited: 16

Influence of neuropathic pain on nicotinic acetylcholine receptor plasticity and behavioral responses to nicotine in rats
Gloria Brunori, Jennifer J. Schoch, Daniela Mercatelli, et al.
Pain (2018) Vol. 159, Iss. 11, pp. 2179-2191
Open Access | Times Cited: 16

Alcoholic Neuropathy: Involvement of Multifaceted Signalling Mechanisms
Tapan Behl, Harlokesh Narayan Yadav, Pyare Lal Sharma
Current Molecular Pharmacology (2020) Vol. 14, Iss. 1, pp. 2-10
Closed Access | Times Cited: 13

Potent and selective NOP receptor activation reduces cocaine self‐administration in rats by lowering hedonic set point
Andrea Cippitelli, Megan E. Barnes, Nurulain T. Zaveri, et al.
Addiction Biology (2019) Vol. 25, Iss. 6
Closed Access | Times Cited: 12

PPL-138 (BU10038): A bifunctional NOP/mu partial agonist that reduces cocaine self-administration in rats
Andrea Cippitelli, Madeline Martinez, Gilles Zribi, et al.
Neuropharmacology (2022) Vol. 211, pp. 109045-109045
Open Access | Times Cited: 8

Altered mRNA Levels of Stress-Related Peptides in Mouse Hippocampus and Caudate-Putamen in Withdrawal after Long-Term Intermittent Exposure to Tobacco Smoke or Electronic Cigarette Vapour
Lucia Carboni, Luisa Ponzoni, Daniela Braida, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 599-599
Open Access | Times Cited: 10

Highly Selective and Potent α4β2 nAChR Antagonist Inhibits Nicotine Self-Administration and Reinstatement in Rats
Jinhua Wu, Andrea Cippitelli, Yaohong Zhang, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 24, pp. 10092-10104
Open Access | Times Cited: 10

Differential regulation of alcohol taking and seeking by antagonism at α4β2 and α3β4 nAChRs
Andrea Cippitelli, Gloria Brunori, Jennifer J. Schoch, et al.
Psychopharmacology (2018) Vol. 235, Iss. 6, pp. 1745-1757
Open Access | Times Cited: 10

Potential of Nociceptin/Orphanin FQ Peptide Analogs for Drug Development
Karol Wtorek, Anna Janecka
Chemistry & Biodiversity (2020) Vol. 18, Iss. 1
Closed Access | Times Cited: 8

NOP Receptor Agonist Ro 64-6198 Decreases Escalation of Cocaine Self-Administration in Rats Genetically Selected for Alcohol Preference
Hongwu Li, Giulia Scuppa, Qianwei Shen, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 6

Targeting the Opioid Receptors: A Promising Therapeutic Avenue for Treatment in “Heavy Drinking Smokers”
Ana Domi, Estelle Barbier, Louise Adermark, et al.
Alcohol and Alcoholism (2020) Vol. 56, Iss. 2, pp. 127-138
Closed Access | Times Cited: 6

Page 1 - Next Page

Scroll to top